BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+3.83%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$6.15B
AUM Growth
+$6.15B
(-6.1%)
Cap. Flow
-$279M
Cap. Flow
% of AUM
-4.53%
Top 10 Holdings %
Top 10 Hldgs %
39.96%
Holding
178
New
9
Increased
65
Reduced
60
Closed
12
Top Buys
| 1 |
Stryker
SYK
|
$32.9M |
| 2 |
Biohaven
BHVN
|
$30.9M |
| 3 |
UnitedHealth
UNH
|
$29M |
| 4 |
Insulet
PODD
|
$28.6M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$26.5M |
Top Sells
| 1 |
Insmed
INSM
|
$75M |
| 2 |
Intuitive Surgical
ISRG
|
$63.3M |
| 3 |
argenx
ARGX
|
$51.2M |
| 4 |
Boston Scientific
BSX
|
$44.6M |
| 5 |
Humana
HUM
|
$40M |
Sector Composition
| 1 | Healthcare | 99.91% |
| 2 | Industrials | 0.05% |
| 3 | Communication Services | 0.02% |
| 4 | Technology | 0.02% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Baidu
BIDU
$33.1B
| $173K | ﹤0.01% |
2,000
| – | – |
|
152
West Pharmaceutical
WST
$17.9B
| $171K | ﹤0.01% |
520
-350
| -40% | -$115K |
|
153
Garmin
GRMN
$45.6B
| $171K | ﹤0.01% |
1,050
-1,750
| -63% | -$285K |
|
154
Ultragenyx Pharmaceutical
RARE
$3.04B
| $164K | ﹤0.01% |
+4,000
| New | +$164K |
|
155
Arcutis Biotherapeutics
ARQT
$1.91B
| $163K | ﹤0.01% |
+17,500
| New | +$163K |
|
|
AUTL
156
Autolus Therapeutics
AUTL
$383M
| $113K | ﹤0.01% |
32,500
| – | – |
|
|
GRAL
157
GRAIL, Inc. Common Stock
GRAL
$1.17B
| $112K | ﹤0.01% |
+7,266
| New | +$112K |
|
158
Agilent Technologies
A
$35.5B
| $91.3K | ﹤0.01% |
704
+164
| +30% | +$21.3K |
|
159
NVIDIA
NVDA
$4.15T
| $80.9K | ﹤0.01% |
655
-315
| -32% | -$38.9K |
|
160
Oracle
ORCL
$628B
| $80.6K | ﹤0.01% |
571
-106
| -16% | -$15K |
|
161
Microsoft
MSFT
$3.76T
| $80K | ﹤0.01% |
179
-1
| -0.6% | -$447 |
|
162
Qualcomm
QCOM
$170B
| $77.9K | ﹤0.01% |
391
-126
| -24% | -$25.1K |
|
163
Mettler-Toledo International
MTD
$26.1B
| $55.9K | ﹤0.01% |
40
+7
| +21% | +$9.78K |
|
164
OmniAb
OABI
$219M
| $43K | ﹤0.01% |
11,456
| – | – |
|
165
Labcorp
LH
$22.8B
| $38.7K | ﹤0.01% |
190
+42
| +28% | +$8.55K |
|
|
EXAI
166
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $17.1K | ﹤0.01% |
3,350
+706
| +27% | +$3.6K |
|
167
Baxter International
BAX
$12.1B
| – | – |
-4,200
| Closed | -$180K |
|
168
Biomea Fusion
BMEA
$114M
| – | – |
-17,800
| Closed | -$266K |
|
169
Bristol-Myers Squibb
BMY
$96.7B
| – | – |
-23,436
| Closed | -$1.27M |
|
170
VanEck Gold Miners ETF
GDX
$19.6B
| – | – |
-33,000
| Closed | -$1.04M |
|
171
IonQ
IONQ
$12.2B
| – | – |
-1,107
| Closed | -$11.1K |
|
172
Pacific Biosciences
PACB
$378M
| – | – |
-4,592,251
| Closed | -$17.2M |
|
173
Regenxbio
RGNX
$498M
| – | – |
-12,000
| Closed | -$253K |
|
174
Simply Good Foods
SMPL
$2.88B
| – | – |
-7,900
| Closed | -$269K |
|
175
SPDR S&P 500 ETF Trust
SPY
$656B
| – | – |
-6,660
| Closed | -$3.48M |
|